Evaluation of total serum bilirubin thresholds for discontinuing phototherapy in jaundiced neonates: a randomized study

Background To evaluate the outcomes of jaundiced neonates using 2 different total serum bilirubin (TSB) thresholds for discontinuing phototherapy. Purpose The study aims to evaluate the outcomes of jaundiced neonates by comparing 2 different TSB thresholds for discontinuing phototherapy. Methods All...

Full description

Saved in:
Bibliographic Details
Main Authors: Ajay Kumar, Nidhi Jain
Format: Article
Language:English
Published: The Korean Pediatric Society 2025-07-01
Series:Clinical and Experimental Pediatrics
Subjects:
Online Access:http://e-cep.org/upload/pdf/cep-2024-01249.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849416377066061824
author Ajay Kumar
Nidhi Jain
author_facet Ajay Kumar
Nidhi Jain
author_sort Ajay Kumar
collection DOAJ
description Background To evaluate the outcomes of jaundiced neonates using 2 different total serum bilirubin (TSB) thresholds for discontinuing phototherapy. Purpose The study aims to evaluate the outcomes of jaundiced neonates by comparing 2 different TSB thresholds for discontinuing phototherapy. Methods All consecutive jaundiced neonates in a tertiary care hospital with a gestational age of ≥35 weeks and ≥3 days postnatal age were randomly assigned to 2 groups. Results Eighty neonates were included. The mean±standard deviation TSB at the time of phototherapy discontinuation was 13.1±2.2 mg/dL in the recommended threshold group and 10.5±2.5 mg/dL in the low threshold group. After discontinuing phototherapy, 17 infants in the recommended threshold group and 21 in the low threshold group experienced an increased TSB, with 3 and 9 crossing the treatment threshold, respectively. Following the National Institute for Health and Clinical Excellence (NICE) guidelines, there was a 14.3% increase in the reinstitution of treatment, averaging 28.11 hours with no reported adverse outcomes. Conclusion Discontinuation of phototherapy in neonates led to increased TSB levels, with a reinstitution rate of 14.3%. While adherence to the NICE guidelines is important, careful posttreatment monitoring is essential. Incorporating the 2022 American Academy of Pediatrics guidelines into future research could provide a more comprehensive understanding of safe practices in this area.
format Article
id doaj-art-51b4322bb45a42d9ad83e3a3335fa947
institution Kabale University
issn 2713-4148
language English
publishDate 2025-07-01
publisher The Korean Pediatric Society
record_format Article
series Clinical and Experimental Pediatrics
spelling doaj-art-51b4322bb45a42d9ad83e3a3335fa9472025-08-20T03:33:11ZengThe Korean Pediatric SocietyClinical and Experimental Pediatrics2713-41482025-07-0168753954510.3345/cep.2024.0124920125555791Evaluation of total serum bilirubin thresholds for discontinuing phototherapy in jaundiced neonates: a randomized studyAjay Kumar0Nidhi Jain1 Department of Neonatology, Maulana Azad Medical College, New Delhi, India Department of Neonatology, Maulana Azad Medical College, New Delhi, IndiaBackground To evaluate the outcomes of jaundiced neonates using 2 different total serum bilirubin (TSB) thresholds for discontinuing phototherapy. Purpose The study aims to evaluate the outcomes of jaundiced neonates by comparing 2 different TSB thresholds for discontinuing phototherapy. Methods All consecutive jaundiced neonates in a tertiary care hospital with a gestational age of ≥35 weeks and ≥3 days postnatal age were randomly assigned to 2 groups. Results Eighty neonates were included. The mean±standard deviation TSB at the time of phototherapy discontinuation was 13.1±2.2 mg/dL in the recommended threshold group and 10.5±2.5 mg/dL in the low threshold group. After discontinuing phototherapy, 17 infants in the recommended threshold group and 21 in the low threshold group experienced an increased TSB, with 3 and 9 crossing the treatment threshold, respectively. Following the National Institute for Health and Clinical Excellence (NICE) guidelines, there was a 14.3% increase in the reinstitution of treatment, averaging 28.11 hours with no reported adverse outcomes. Conclusion Discontinuation of phototherapy in neonates led to increased TSB levels, with a reinstitution rate of 14.3%. While adherence to the NICE guidelines is important, careful posttreatment monitoring is essential. Incorporating the 2022 American Academy of Pediatrics guidelines into future research could provide a more comprehensive understanding of safe practices in this area.http://e-cep.org/upload/pdf/cep-2024-01249.pdfneonatehyperbilirubinemiaphototherapy discontinuation
spellingShingle Ajay Kumar
Nidhi Jain
Evaluation of total serum bilirubin thresholds for discontinuing phototherapy in jaundiced neonates: a randomized study
Clinical and Experimental Pediatrics
neonate
hyperbilirubinemia
phototherapy discontinuation
title Evaluation of total serum bilirubin thresholds for discontinuing phototherapy in jaundiced neonates: a randomized study
title_full Evaluation of total serum bilirubin thresholds for discontinuing phototherapy in jaundiced neonates: a randomized study
title_fullStr Evaluation of total serum bilirubin thresholds for discontinuing phototherapy in jaundiced neonates: a randomized study
title_full_unstemmed Evaluation of total serum bilirubin thresholds for discontinuing phototherapy in jaundiced neonates: a randomized study
title_short Evaluation of total serum bilirubin thresholds for discontinuing phototherapy in jaundiced neonates: a randomized study
title_sort evaluation of total serum bilirubin thresholds for discontinuing phototherapy in jaundiced neonates a randomized study
topic neonate
hyperbilirubinemia
phototherapy discontinuation
url http://e-cep.org/upload/pdf/cep-2024-01249.pdf
work_keys_str_mv AT ajaykumar evaluationoftotalserumbilirubinthresholdsfordiscontinuingphototherapyinjaundicedneonatesarandomizedstudy
AT nidhijain evaluationoftotalserumbilirubinthresholdsfordiscontinuingphototherapyinjaundicedneonatesarandomizedstudy